Experienced in Hereditary Spherocytosis

Dr. Subhash C. Sharma

Hematology Oncology
Swedish Health Services
1221 Madison St, Suite 1020, 
Seattle, WA 
Accepting New Patients
Offers Telehealth
Experienced in Hereditary Spherocytosis
Swedish Health Services
1221 Madison St, Suite 1020, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Subhash Sharma is a Hematologist Oncology provider in Seattle, Washington. Dr. Sharma and is rated as an Experienced provider by MediFind in the treatment of Hereditary Spherocytosis. His top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Acute Promyelocytic Leukemia, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Sharma is currently accepting new patients.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Internal Medicine in IN
Hospital Affiliations
Decatur County Memorial Hospital
Swedish Medical Center
Languages Spoken
English
Hindi
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

SWEDISH HEALTH SERVICES
1221 Madison St, Suite 1020, Seattle, WA 98104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 12, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Entinostat, Exemestane, Goserelin, Goserelin Acetate
Study Phase: Phase 3
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 30, 2025
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Exemestane, Letrozole, Systemic Chemotherapy
Study Phase: Phase 3
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: May 21, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
Evaluation of Mammographic Breast Density Effect of Aspirin: a Companion Study to Alliance Study A011502
Evaluation of Mammographic Breast Density Effect of Aspirin: a Companion Study to Alliance Study A011502
Enrollment Status: Terminated
Publish Date: January 16, 2025
Intervention Type: Procedure
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
Combination Immunotherapy With Herceptin and the HER2 Vaccine E75 in Low and Intermediate HER2-expressing Breast Cancer Patients to Prevent Recurrence
Combination Immunotherapy With Herceptin and the HER2 Vaccine E75 in Low and Intermediate HER2-expressing Breast Cancer Patients to Prevent Recurrence
Enrollment Status: Completed
Publish Date: December 02, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

2 Total Publications

Embolia Cutis Medicamentosa (Nicolau Syndrome) Secondary to Intramuscular Fulvestrant Injection: A Case Report.
Embolia Cutis Medicamentosa (Nicolau Syndrome) Secondary to Intramuscular Fulvestrant Injection: A Case Report.
Journal: Journal of pharmacy practice
Published: April 29, 2021
Similar Doctors
Ganapathy S. Krishnan
Advanced in Hereditary Spherocytosis
Dr. Ganapathy S. Krishnan
Hematology Oncology | Hematology | Oncology
Advanced in Hereditary Spherocytosis
Dr. Ganapathy S. Krishnan
Hematology Oncology | Hematology | Oncology

Salish Integrative Medicine Inc

3700 Pacific Hwy E, Suite 100, 
Fife, WA 
 (25.6 mi)
253-382-6300
Languages Spoken:
English, Arabic, French, Korean, Russian, Spanish, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Ganapathy Krishnan is a Hematologist Oncology specialist and a Hematologist in Fife, Washington. Dr. Krishnan and is rated as an Advanced provider by MediFind in the treatment of Hereditary Spherocytosis. His top areas of expertise are Follicular Lymphoma, Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Large-Cell Lung Carcinoma. Dr. Krishnan is currently accepting new patients.

Advanced in Hereditary Spherocytosis
Dr. Kurt A. Norman
Hematology Oncology | Hematology | Oncology
Advanced in Hereditary Spherocytosis
Dr. Kurt A. Norman
Hematology Oncology | Hematology | Oncology

The Association Of University Physicians

728 Edmonds Way, Rosewood Courte Memory Care, 
Edmonds, WA 
 (13.5 mi)
425-673-2875
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kurt Norman is a Hematologist Oncology specialist and a Hematologist in Edmonds, Washington. Dr. Norman and is rated as a Distinguished provider by MediFind in the treatment of Hereditary Spherocytosis. His top areas of expertise are Anal Cancer, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Lung Adenocarcinoma. Dr. Norman is currently accepting new patients.

Experienced in Hereditary Spherocytosis
Dr. Prakash D. Vishnu
Hematology Oncology | Hematology | Oncology
Experienced in Hereditary Spherocytosis
Dr. Prakash D. Vishnu
Hematology Oncology | Hematology | Oncology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (1.2 mi)
206-288-1000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Prakash Vishnu is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Vishnu and is rated as a Distinguished provider by MediFind in the treatment of Hereditary Spherocytosis. His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Splenectomy, and Bone Marrow Aspiration. Dr. Vishnu is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sharma's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 49 Advanced Conditions
    View All 116 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile